A 0 1 0 1 O
repeated 2 10 2 10 O
CT 11 13 11 13 O
or 14 16 14 16 O
MRI 17 20 17 20 O
following 21 30 21 30 O
the 31 34 31 34 O
identification 35 49 35 49 O
of 50 52 50 52 O
CNS 53 56 53 56 B-cancer
metastases 57 67 57 67 I-cancer
( 68 69 68 69 O
obtained 69 77 69 77 O
at 78 80 78 80 O
least 81 86 81 86 O
2 87 88 87 88 B-lower_bound
weeks 89 94 89 94 I-lower_bound
after 95 100 95 100 O
definitive 101 111 101 111 B-treatment
therapy 112 119 112 119 I-treatment
) 119 120 119 120 O
must 121 125 121 125 O
document 126 134 126 134 O
adequately 135 145 135 145 O
treated 146 153 146 153 O
brain 154 159 154 159 B-cancer
metastases 160 170 160 170 I-cancer

Able 0 4 171 175 O
to 5 7 176 178 O
take 8 12 179 183 O
oral 13 17 184 188 O
medications 18 29 189 200 B-treatment

Absolute 0 8 201 209 B-clinical_variable
neutrophil 9 19 210 220 I-clinical_variable
count 20 25 221 226 I-clinical_variable
( 26 27 227 228 I-clinical_variable
ANC 27 30 228 231 I-clinical_variable
) 30 31 231 232 I-clinical_variable
≥ 32 33 233 234 O
1500 34 38 235 239 B-lower_bound
/ 38 39 239 240 I-lower_bound
mm^3 39 43 240 244 I-lower_bound

Active 0 6 245 251 O
, 6 7 251 252 O
clinically 8 18 253 263 O
significant 19 30 264 275 O
infection 31 40 276 285 O
either 41 47 286 292 O
grade 48 53 293 298 O
> 54 55 299 300 O
2 56 57 301 302 B-lower_bound
by 58 60 303 305 O
National 61 69 306 314 O
Cancer 70 76 315 321 O
Institute 77 86 322 331 O
( 87 88 332 333 O
NCI 88 91 333 336 O
) 91 92 336 337 O
Common 93 99 338 344 O
Terminology 100 111 345 356 O
Criteria 112 120 357 365 O
for 121 124 366 369 O
Adverse 125 132 370 377 O
Events 133 139 378 384 O
( 140 141 385 386 O
CTCAE 141 146 386 391 O
) 146 147 391 392 O
version 148 155 393 400 O
4.0 156 159 401 404 O
or 160 162 405 407 O
requiring 163 172 408 417 O
the 173 176 418 421 O
use 177 180 422 425 O
of 181 183 426 428 O
parenteral 184 194 429 439 B-treatment
anti 195 199 440 444 I-treatment
- 199 200 444 445 I-treatment
microbial 200 209 445 454 I-treatment
agents 210 216 455 461 I-treatment
within 217 223 462 468 O
7 224 225 469 470 B-upper_bound
days 226 230 471 475 I-upper_bound
before 231 237 476 482 O
day 238 241 483 486 O
1 242 243 487 488 O
of 244 246 489 491 O
study 247 252 492 497 O
drug 253 257 498 502 O

Adequately 0 10 503 513 O
treated 11 18 514 521 O
brain 19 24 522 527 B-cancer
metastases 25 35 528 538 I-cancer
documented 36 46 539 549 O
by 47 49 550 552 O
baseline 50 58 553 561 O
computed 59 67 562 570 B-treatment
tomography 68 78 571 581 I-treatment
( 79 80 582 583 I-treatment
CT 80 82 583 585 I-treatment
) 82 83 585 586 I-treatment
or 84 86 587 589 O
magnetic 87 95 590 598 B-treatment
resonance 96 105 599 608 I-treatment
imaging 106 113 609 616 I-treatment
( 114 115 617 618 I-treatment
MRI 115 118 618 621 I-treatment
) 118 119 621 622 I-treatment
scan 120 124 623 627 I-treatment
that 125 129 628 632 O
have 130 134 633 637 O
not 135 138 638 641 O
progressed 139 149 642 652 O
since 150 155 653 658 O
previous 156 164 659 667 O
scans 165 170 668 673 O
and 171 174 674 677 O
do 175 177 678 680 O
not 178 181 681 684 O
require 182 189 685 692 O
corticosteroids 190 205 693 708 B-treatment
( 206 207 709 710 O
except 207 213 710 716 O
prednisone 214 224 717 727 B-treatment
≤ 225 226 728 729 O
5 227 228 730 731 B-upper_bound
mg 229 231 732 734 I-upper_bound
/ 231 232 734 735 I-upper_bound
day 232 235 735 738 I-upper_bound
or 236 238 739 741 O
equivalent 239 249 742 752 O
) 249 250 752 753 O
for 251 254 754 757 O
management 255 265 758 768 O
of 266 268 769 771 O
CNS 269 272 772 775 O
symptoms 273 281 776 784 O

An 0 2 785 787 O
homologous 3 13 788 798 B-clinical_variable
recombination 14 27 799 812 I-clinical_variable
deficiency 28 38 813 823 I-clinical_variable
( 39 40 824 825 I-clinical_variable
HRD 40 43 825 828 I-clinical_variable
) 43 44 828 829 I-clinical_variable
score 45 50 830 835 O
≥ 51 52 836 837 O
42 53 55 838 840 B-lower_bound
on 56 58 841 843 O
the 59 62 844 847 O
HRD 63 66 848 851 O
Assay 67 72 852 857 O
as 73 75 858 860 O
assessed 76 84 861 869 O
on 85 87 870 872 O
a 88 89 873 874 O
tumor 90 95 875 880 B-cancer
biopsy 96 102 881 887 B-treatment
sample 103 109 888 894 O

Any 0 3 895 898 O
anti 4 8 899 903 B-treatment
- 8 9 903 904 I-treatment
cancer 9 15 904 910 I-treatment
therapy 16 23 911 918 I-treatment
within 24 30 919 925 O
the 31 34 926 929 O
past 35 39 930 934 B-upper_bound
21 40 42 935 937 I-upper_bound
days 43 47 938 942 I-upper_bound
of 48 50 943 945 O
the 51 54 946 949 O
first 55 60 950 955 O
day 61 64 956 959 O
of 65 67 960 962 O
treatment 68 77 963 972 O

Brain 0 5 973 978 B-cancer
or 6 8 979 981 I-cancer
central 9 16 982 989 I-cancer
nervous 17 24 990 997 I-cancer
system 25 31 998 1004 I-cancer
( 32 33 1005 1006 I-cancer
CNS 33 36 1006 1009 I-cancer
) 36 37 1009 1010 I-cancer
metastases 38 48 1011 1021 I-cancer

Calculated 0 10 1022 1032 B-clinical_variable
creatinine 11 21 1033 1043 I-clinical_variable
clearance 22 31 1044 1053 I-clinical_variable
≥ 32 33 1054 1055 O
30 34 36 1056 1058 B-lower_bound
mL 37 39 1059 1061 I-lower_bound
/ 39 40 1061 1062 I-lower_bound
min 40 43 1062 1065 I-lower_bound
or 44 46 1066 1068 O
serum 47 52 1069 1074 B-clinical_variable
creatinine 53 63 1075 1085 I-clinical_variable
≤ 64 65 1086 1087 O
1.5 66 69 1088 1091 B-upper_bound
mg 70 72 1092 1094 I-upper_bound
/ 72 73 1094 1095 I-upper_bound
dL 73 75 1095 1097 I-upper_bound

Clinically 0 10 1098 1108 O
significant 11 22 1109 1120 O
bleeding 23 31 1121 1129 B-chronic_disease
diathesis 32 41 1130 1139 I-chronic_disease
or 42 44 1140 1142 O
coagulopathy 45 57 1143 1155 B-chronic_disease
, 57 58 1155 1156 O
including 59 68 1157 1166 O
known 69 74 1167 1172 O
platelet 75 83 1173 1181 B-chronic_disease
function 84 92 1182 1190 I-chronic_disease
disorders 93 102 1191 1200 I-chronic_disease

Deleterious 0 11 1201 1212 O
germline 12 20 1213 1221 O
or 21 23 1222 1224 O
somatic 24 31 1225 1232 O
mutation 32 40 1233 1241 O
implicated 41 51 1242 1252 O
in 52 54 1253 1255 O
the 55 58 1256 1259 O
homologous 59 69 1260 1270 O
recombination 70 83 1271 1284 O
( 84 85 1285 1286 O
HR 85 87 1286 1288 O
) 87 88 1288 1289 O
pathway 89 96 1290 1297 O
, 96 97 1297 1298 O
excluding 98 107 1299 1308 O
BRCA1 108 113 1309 1314 B-cancer
or 114 116 1315 1317 O
BRCA2 117 122 1318 1323 B-cancer
, 122 123 1323 1324 O
based 124 129 1325 1330 O
on 130 132 1331 1333 O
germline 133 141 1334 1342 O
multiplex 142 151 1343 1352 O
gene 152 156 1353 1357 O
testing 157 164 1358 1365 O
or 165 167 1366 1368 O
direct 168 174 1369 1375 O
tumor 175 180 1376 1381 O
next 181 185 1382 1386 O
generation 186 196 1387 1397 O
DNA 197 200 1398 1401 O
sequencing 201 211 1402 1412 O

Eastern 0 7 1413 1420 B-clinical_variable
Cooperative 8 19 1421 1432 I-clinical_variable
Oncology 20 28 1433 1441 I-clinical_variable
Group 29 34 1442 1447 I-clinical_variable
( 35 36 1448 1449 I-clinical_variable
ECOG 36 40 1449 1453 I-clinical_variable
) 40 41 1453 1454 I-clinical_variable
performance 42 53 1455 1466 I-clinical_variable
status 54 60 1467 1473 I-clinical_variable
of 61 63 1474 1476 O
0 64 65 1477 1478 B-lower_bound
to 66 68 1479 1481 O
2 69 70 1482 1483 B-upper_bound

Females 0 7 1484 1491 B-gender
of 8 10 1492 1494 O
childbearing 11 23 1495 1507 O
potential 24 33 1508 1517 O
must 34 38 1518 1522 O
have 39 43 1523 1527 O
a 44 45 1528 1529 O
negative 46 54 1530 1538 B-pregnancy
serum 55 60 1539 1544 I-pregnancy
pregnancy 61 70 1545 1554 I-pregnancy
test 71 75 1555 1559 O
at 76 78 1560 1562 O
screening 79 88 1563 1572 O
and 89 92 1573 1576 O
be 93 95 1577 1579 O
willing 96 103 1580 1587 O
to 104 106 1588 1590 O
have 107 111 1591 1595 O
additional 112 122 1596 1606 O
serum 123 128 1607 1612 O
pregnancy 129 138 1613 1622 O
tests 139 144 1623 1628 O
during 145 151 1629 1635 O
the 152 155 1636 1639 O
study 156 161 1640 1645 O

HER2 0 4 1646 1650 B-cancer
positive 5 13 1651 1659 I-cancer
breast 14 20 1660 1666 I-cancer
cancer 21 27 1667 1673 I-cancer
( 28 29 1674 1675 O
Cohort 29 35 1675 1681 O
B 36 37 1682 1683 O
only 38 42 1684 1688 O
) 42 43 1688 1689 O

Hemoglobin 0 10 1690 1700 B-clinical_variable
≥ 11 12 1701 1702 O
9.0 13 16 1703 1706 B-lower_bound
g 17 18 1707 1708 I-lower_bound
/ 18 19 1708 1709 I-lower_bound
dL 19 21 1709 1711 I-lower_bound
with 22 26 1712 1716 O
last 27 31 1717 1721 O
transfusion 32 43 1722 1733 O
at 44 46 1734 1736 O
least 47 52 1737 1742 O
14 53 55 1743 1745 B-lower_bound
days 56 60 1746 1750 I-lower_bound
before 61 67 1751 1757 O
day 68 71 1758 1761 O
1 72 73 1762 1763 O
of 74 76 1764 1766 O
study 77 82 1767 1772 O
drug 83 87 1773 1777 O

Histologically 0 14 1778 1792 O
- 14 15 1792 1793 O
confirmed 15 24 1793 1802 O
metastatic 25 35 1803 1813 B-cancer
or 36 38 1814 1816 O
recurrent 39 48 1817 1826 O
HER2 49 53 1827 1831 B-cancer
- 53 54 1831 1832 O
negative 54 62 1832 1840 O
( 63 64 1841 1842 O
via 64 67 1842 1845 O
IHC 68 71 1846 1849 B-treatment
or 72 74 1850 1852 O
FISH 75 79 1853 1857 B-treatment
) 79 80 1857 1858 O
breast 81 87 1859 1865 B-cancer
cancer 88 94 1866 1872 I-cancer
or 95 97 1873 1875 O
other 98 103 1876 1881 O
histologically 104 118 1882 1896 O
- 118 119 1896 1897 O
confirmed 119 128 1897 1906 O
metastatic 129 139 1907 1917 B-cancer
solid 140 145 1918 1923 I-cancer
tumor 146 151 1924 1929 I-cancer

Histologically 0 14 1930 1944 O
- 14 15 1944 1945 O
confirmed 15 24 1945 1954 O
metastatic 25 35 1955 1965 O
or 36 38 1966 1968 O
recurrent 39 48 1969 1978 O
triple 49 55 1979 1985 B-cancer
- 55 56 1985 1986 I-cancer
negative 56 64 1986 1994 I-cancer
breast 65 71 1995 2001 I-cancer
cancer 72 78 2002 2008 I-cancer
( 79 80 2009 2010 O
defined 80 87 2010 2017 O
as 88 90 2018 2020 O
estrogen 91 99 2021 2029 B-clinical_variable
receptor 100 108 2030 2038 I-clinical_variable
≤ 109 110 2039 2040 I-treatment
5 111 112 2041 2042 I-treatment
% 112 113 2042 2043 I-treatment
, 113 114 2043 2044 I-treatment
progesterone 115 127 2045 2057 I-treatment
receptor 128 136 2058 2066 I-treatment
≤ 137 138 2067 2068 I-treatment
5 139 140 2069 2070 I-treatment
% 140 141 2070 2071 I-treatment
, 141 142 2071 2072 I-treatment
HER2 143 147 2073 2077 I-treatment
- 147 148 2077 2078 I-treatment
negative 148 156 2078 2086 I-treatment
via 157 160 2087 2090 I-treatment
immunohistochemistry 161 181 2091 2111 I-treatment
[ 182 183 2112 2113 I-treatment
IHC 183 186 2113 2116 I-treatment
] 186 187 2116 2117 I-treatment
or 188 190 2118 2120 I-treatment
fluorescent 191 202 2121 2132 I-treatment
in 203 205 2133 2135 I-treatment
situ 206 210 2136 2140 I-treatment
hybridization 211 224 2141 2154 I-treatment
[ 225 226 2155 2156 O
FISH 226 230 2156 2160 O
] 230 231 2160 2161 O
) 231 232 2161 2162 O

Hormone 0 7 2163 2170 O
receptor 8 16 2171 2179 O
positive 17 25 2180 2188 O
and/or 26 32 2189 2195 O
HER2 33 37 2196 2200 B-cancer
positive 38 46 2201 2209 I-cancer
breast 47 53 2210 2216 I-cancer
cancer 54 60 2217 2223 I-cancer
( 61 62 2224 2225 O
Cohort 62 68 2225 2231 O
A 69 70 2232 2233 O
only 71 75 2234 2238 O
) 75 76 2238 2239 O

If 0 2 2240 2242 O
prior 3 8 2243 2248 O
platinum 9 17 2249 2257 O
agent 18 23 2258 2263 O
( 24 25 2264 2265 O
eg 25 27 2265 2267 O
, 27 28 2267 2268 O
carboplatin 29 40 2269 2280 B-treatment
or 41 43 2281 2283 O
cisplatin 44 53 2284 2293 B-treatment
) 53 54 2293 2294 O
has 55 58 2295 2298 O
been 59 63 2299 2303 O
administered 64 76 2304 2316 O
, 76 77 2316 2317 O
no 78 80 2318 2320 O
evidence 81 89 2321 2329 O
of 90 92 2330 2332 O
progression 93 104 2333 2344 O
, 104 105 2344 2345 O
or 106 108 2346 2348 O
within 109 115 2349 2355 O
8 116 117 2356 2357 B-upper_bound
weeks 118 123 2358 2363 I-upper_bound
of 124 126 2364 2366 O
stopping 127 135 2367 2375 O
platinum 136 144 2376 2384 B-treatment
treatment 145 154 2385 2394 I-treatment

Known 0 5 2395 2400 O
active 6 12 2401 2407 O
hepatitis 13 22 2408 2417 B-chronic_disease
B 23 24 2418 2419 I-chronic_disease
virus 25 30 2420 2425 I-chronic_disease

Known 0 5 2426 2431 O
active 6 12 2432 2438 O
hepatitis 13 22 2439 2448 B-chronic_disease
C 23 24 2449 2450 I-chronic_disease
virus 25 30 2451 2456 I-chronic_disease

Known 0 5 2457 2462 O
hypersensitivity 6 22 2463 2479 O
to 23 25 2480 2482 O
any 26 29 2483 2486 O
of 30 32 2487 2489 O
the 33 36 2490 2493 O
components 37 47 2494 2504 O
of 48 50 2505 2507 O
BMN 51 54 2508 2511 B-allergy_name
673 55 58 2512 2515 I-allergy_name

Known 0 5 2516 2521 O
to 6 8 2522 2524 O
be 9 11 2525 2527 O
human 12 17 2528 2533 B-chronic_disease
immunodeficiency 18 34 2534 2550 I-chronic_disease
virus 35 40 2551 2556 I-chronic_disease
positive 41 49 2557 2565 I-chronic_disease

Major 0 5 2566 2571 B-treatment
surgery 6 13 2572 2579 I-treatment
requiring 14 23 2580 2589 O
a 24 25 2590 2591 O
prolonged 26 35 2592 2601 O
hospitalization 36 51 2602 2617 O
or 52 54 2618 2620 O
recovery 55 63 2621 2629 O
within 64 70 2630 2636 O
21 71 73 2637 2639 B-upper_bound
days 74 78 2640 2644 I-upper_bound
before 79 85 2645 2651 O
day 86 89 2652 2655 O
1 90 91 2656 2657 O
of 92 94 2658 2660 O
study 95 100 2661 2666 B-treatment
drug 101 105 2667 2671 I-treatment

Must 0 4 2672 2676 O
have 5 9 2677 2681 O
progressed 10 20 2682 2692 O
on 21 23 2693 2695 O
at 24 26 2696 2698 O
least 27 32 2699 2704 O
1 33 34 2705 2706 B-lower_bound
prior 35 40 2707 2712 B-treatment
chemotherapy 41 53 2713 2725 I-treatment
regimen 54 61 2726 2733 I-treatment
for 62 65 2734 2737 O
the 66 69 2738 2741 O
treatment 70 79 2742 2751 B-treatment
of 80 82 2752 2754 O
advanced 83 91 2755 2763 B-cancer
breast 92 98 2764 2770 I-cancer
cancer 99 105 2771 2777 I-cancer
; 105 106 2777 2778 O
there 107 112 2779 2784 O
is 113 115 2785 2787 O
no 116 118 2788 2790 O
upper 119 124 2791 2796 O
limit 125 130 2797 2802 O
on 131 133 2803 2805 O
the 134 137 2806 2809 O
number 138 144 2810 2816 O
of 145 147 2817 2819 O
prior 148 153 2820 2825 B-treatment
therapies 154 163 2826 2835 I-treatment

No 0 2 2836 2838 O
deleterious 3 14 2839 2850 O
germline 15 23 2851 2859 O
BRCA1 24 29 2860 2865 B-cancer
or 30 32 2866 2868 O
BRCA2 33 38 2869 2874 B-cancer
mutation 39 47 2875 2883 O
based 48 53 2884 2889 O
on 54 56 2890 2892 O
full 57 61 2893 2897 O
sequencing 62 72 2898 2908 O
and 73 76 2909 2912 O
comprehensive 77 90 2913 2926 O
rearrangement 91 104 2927 2940 O
testing 105 112 2941 2948 O
at 113 115 2949 2951 O
an 116 118 2952 2954 O
external 119 127 2955 2963 O
reference 128 137 2964 2973 O
laboratory 138 148 2974 2984 O

Non 0 3 2985 2988 O
- 3 4 2988 2989 O
measurable 4 14 2989 2999 B-chronic_disease
disease 15 22 3000 3007 I-chronic_disease
only 23 27 3008 3012 O

Other 0 5 3013 3018 O
malignancy 6 16 3019 3029 B-cancer
that 17 21 3030 3034 O
is 22 24 3035 3037 O
either 25 31 3038 3044 O
active 32 38 3045 3051 O
or 39 41 3052 3054 O
for 42 45 3055 3058 O
which 46 51 3059 3064 O
patient 52 59 3065 3072 O
has 60 63 3073 3076 O
received 64 72 3077 3085 O
treatment 73 82 3086 3095 B-treatment
in 83 85 3096 3098 O
the 86 89 3099 3102 O
last 90 94 3103 3107 B-upper_bound
five 95 99 3108 3112 I-upper_bound
years 100 105 3113 3118 I-upper_bound
excluding 106 115 3119 3128 O
non 116 119 3129 3132 B-cancer
- 119 120 3132 3133 I-cancer
melanoma 120 128 3133 3141 I-cancer
skin 129 133 3142 3146 I-cancer
cancer 134 140 3147 3153 I-cancer
and 141 144 3154 3157 O
carcinoma 145 154 3158 3167 B-cancer
in 155 157 3168 3170 I-cancer
situ 158 162 3171 3175 I-cancer
of 163 165 3176 3178 I-cancer
the 166 169 3179 3182 I-cancer
cervix 170 176 3183 3189 I-cancer

Platelet 0 8 3190 3198 B-clinical_variable
count 9 14 3199 3204 I-clinical_variable
≥ 15 16 3205 3206 O
100,000 17 24 3207 3214 B-lower_bound
/ 24 25 3214 3215 I-lower_bound
mm^3 25 29 3215 3219 I-lower_bound

Pregnant 0 8 3220 3228 B-pregnancy

Prior 0 5 3229 3234 B-treatment
treatment 6 15 3235 3244 I-treatment
with 16 20 3245 3249 I-treatment
a 21 22 3250 3251 I-treatment
PARP 23 27 3252 3256 I-treatment
inhibitor 28 37 3257 3266 I-treatment

Radiation 0 9 3267 3276 B-treatment
therapy 10 17 3277 3284 I-treatment
in 18 20 3285 3287 O
the 21 24 3288 3291 O
last 25 29 3292 3296 O
14 30 32 3297 3299 B-upper_bound
days 33 37 3300 3304 I-upper_bound

Serum 0 5 3305 3310 B-clinical_variable
aspartate 6 15 3311 3320 I-clinical_variable
aminotransferase 16 32 3321 3337 I-clinical_variable
( 33 34 3338 3339 I-clinical_variable
AST 34 37 3339 3342 I-clinical_variable
) 37 38 3342 3343 I-clinical_variable
and 39 42 3344 3347 O
alanine 43 50 3348 3355 B-clinical_variable
aminotransferase 51 67 3356 3372 I-clinical_variable
( 68 69 3373 3374 I-clinical_variable
ALT 69 72 3374 3377 I-clinical_variable
) 72 73 3377 3378 I-clinical_variable
≤ 74 75 3379 3380 O
2.5 76 79 3381 3384 B-upper_bound
x 80 81 3385 3386 I-upper_bound
upper 82 87 3387 3392 I-upper_bound
limit 88 93 3393 3398 I-upper_bound
of 94 96 3399 3401 I-upper_bound
normal 97 103 3402 3408 I-upper_bound
( 104 105 3409 3410 I-upper_bound
ULN 105 108 3410 3413 I-upper_bound
) 108 109 3413 3414 I-upper_bound

Sexually 0 8 3415 3423 O
active 9 15 3424 3430 O
patients 16 24 3431 3439 O
of 25 27 3440 3442 O
childbearing 28 40 3443 3455 O
potential 41 50 3456 3465 O
must 51 55 3466 3470 O
be 56 58 3471 3473 O
willing 59 66 3474 3481 B-contraception_consent
to 67 69 3482 3484 I-contraception_consent
use 70 73 3485 3488 I-contraception_consent
an 74 76 3489 3491 I-contraception_consent
acceptable 77 87 3492 3502 I-contraception_consent
method 88 94 3503 3509 I-contraception_consent
of 95 97 3510 3512 I-contraception_consent
contraception 98 111 3513 3526 I-contraception_consent
such 112 116 3527 3531 I-contraception_consent
as 117 119 3532 3534 I-contraception_consent
an 120 122 3535 3537 I-contraception_consent
intrauterine 123 135 3538 3550 I-contraception_consent
device 136 142 3551 3557 I-contraception_consent
or 143 145 3558 3560 I-contraception_consent
double 146 152 3561 3567 I-contraception_consent
barrier 153 160 3568 3575 I-contraception_consent
contraception 161 174 3576 3589 I-contraception_consent
during 175 181 3590 3596 O
treatment 182 191 3597 3606 O
and 192 195 3607 3610 O
for 196 199 3611 3614 O
30 200 202 3615 3617 B-upper_bound
days 203 207 3618 3622 I-upper_bound
after 208 213 3623 3628 O
the 214 217 3629 3632 O
last 218 222 3633 3637 O
dose 223 227 3638 3642 O
of 228 230 3643 3645 O
study 231 236 3646 3651 O
drug 237 241 3652 3656 O

Subjects 0 8 3657 3665 O
with 9 13 3666 3670 O
leptomeningeal 14 28 3671 3685 B-cancer
carcinomatosis 29 43 3686 3700 I-cancer

Total 0 5 3701 3706 B-clinical_variable
serum 6 11 3707 3712 I-clinical_variable
bilirubin 12 21 3713 3722 I-clinical_variable
≤ 22 23 3723 3724 O
1.5 24 27 3725 3728 B-upper_bound
x 28 29 3729 3730 I-upper_bound
ULN 30 33 3731 3734 I-upper_bound
( 34 35 3735 3736 O
≤ 35 36 3736 3737 O
3 37 38 3738 3739 B-upper_bound
x 39 40 3740 3741 I-upper_bound
ULN 41 44 3742 3745 I-upper_bound
for 45 48 3746 3749 O
Gilbert 49 56 3750 3757 B-chronic_disease
's 56 58 3757 3759 I-chronic_disease
syndrome 59 67 3760 3768 I-chronic_disease
) 67 68 3768 3769 O

Use 0 3 3770 3773 O
of 4 6 3774 3776 O
any 7 10 3777 3780 O
investigational 11 26 3781 3796 O
product 27 34 3797 3804 O
or 35 37 3805 3807 O
investigational 38 53 3808 3823 B-treatment
medical 54 61 3824 3831 I-treatment
device 62 68 3832 3838 I-treatment
within 69 75 3839 3845 O
28 76 78 3846 3848 B-upper_bound
days 79 83 3849 3853 I-upper_bound
before 84 90 3854 3860 O
day 91 94 3861 3864 O
1 95 96 3865 3866 O
of 97 99 3867 3869 O
study 100 105 3870 3875 O
drug 106 110 3876 3880 O

females 0 7 3881 3888 B-gender
considered 8 18 3889 3899 O
not 19 22 3900 3903 O
of 23 25 3904 3906 O
childbearing 26 38 3907 3919 O
potential 39 48 3920 3929 O
include 49 56 3930 3937 O
those 57 62 3938 3943 O
who 63 66 3944 3947 O
have 67 71 3948 3952 O
been 72 76 3953 3957 O
in 77 79 3958 3960 O
menopause 80 89 3961 3970 O
at 90 92 3971 3973 O
least 93 98 3974 3979 O
2 99 100 3980 3981 B-lower_bound
years 101 106 3982 3987 I-lower_bound
, 106 107 3987 3988 O
or 108 110 3989 3991 O
had 111 114 3992 3995 O
tubal 115 120 3996 4001 B-treatment
ligation 121 129 4002 4010 I-treatment
at 130 132 4011 4013 O
least 133 138 4014 4019 O
1 139 140 4020 4021 B-lower_bound
year 141 145 4022 4026 I-lower_bound
prior 146 151 4027 4032 I-lower_bound
to 152 154 4033 4035 O
screening 155 164 4036 4045 O
, 164 165 4045 4046 O
or 166 168 4047 4049 O
who 169 172 4050 4053 O
have 173 177 4054 4058 O
had 178 181 4059 4062 O
total 182 187 4063 4068 O
hysterectomy 188 200 4069 4081 B-treatment

in 0 2 4082 4084 O
the 3 6 4085 4088 O
case 7 11 4089 4093 O
that 12 16 4094 4098 O
obtaining 17 26 4099 4108 O
an 27 29 4109 4111 O
adequate 30 38 4112 4120 O
metastatic 39 49 4121 4131 B-treatment
tumor 50 55 4132 4137 I-treatment
biopsy 56 62 4138 4144 I-treatment
is 63 65 4145 4147 O
not 66 69 4148 4151 O
possible 70 78 4152 4160 O
, 78 79 4160 4161 O
we 80 82 4162 4164 O
will 83 87 4165 4169 O
assess 88 94 4170 4176 O
the 95 98 4177 4180 O
HRD 99 102 4181 4184 B-clinical_variable
score 103 108 4185 4190 I-clinical_variable
from 109 113 4191 4195 O
the 114 117 4196 4199 O
primary 118 125 4200 4207 O
breast 126 132 4208 4214 B-cancer
tumor 133 138 4215 4220 I-cancer

prednisone 0 10 4221 4231 B-clinical_variable
≤ 11 12 4232 4233 O
5 13 14 4234 4235 B-upper_bound
mg 15 17 4236 4238 I-upper_bound
/ 17 18 4238 4239 I-upper_bound
day 18 21 4239 4242 I-upper_bound
or 22 24 4243 4245 O
equivalent 25 35 4246 4256 O

